window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

pharmaceutical manufacturing

  • Biotech & Pharma Business,Digital & Data,Manufacturing & Supply Chain

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza appoints Jason Berndt as head of group operations and Maria Soler Nunez as chief quality officer

    Lonza has appointed Jason Berndt as head of group operations [...]

    May 5, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    SGD Pharma to acquire Alphial to expand tubular glass and vial manufacturing in Europe

    SGD Pharma has signed an agreement with Italian private equity [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics

    Pharmaceuticals and therapeutics: Lilly to raise drug prices in Europe as it cuts US patient costs

    Lilly has voiced strong support for the US administration’s goal [...]

    May 5, 2026
  • Clinical & Regulatory,Manufacturing & Supply Chain,Uncategorised

    Cherwell to become AnalytiChem UK from September 2025

    Cleanroom microbiology solutions specialist Cherwell is set to be renamed [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Aragen appoints Aniel Khubchandani to lead development and manufacturing solutions business

    Contract research, development and manufacturing organisation Aragen has appointed Aniel [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Symbiosis completes 1,000th batch of sterile injectable drug product

    Contract manufacturer Symbiosis Pharmaceutical Services has announced the completion of [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Colorcon expands global supply network with new pharmaceutical film coating facility in Malaysia

    Colorcon has officially opened a new pharmaceutical film coating manufacturing [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain

    Stevanato Group secures €200 million to support global capacity expansion for drug delivery solutions

    Stevanato Group has secured €200 million in financing to support [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Oral GLP-1 candidate CX11 achieves 11.5% weight loss in US Phase 2 obesity trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE recommends cemiplimab for recurrent or metastatic cervical cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Discovery & Development, Genomics and sequencing, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top